- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited ; volume:49 ; number:1 ; year:2020 ; pages:2-7
Dementia and geriatric cognitive disorders ; 49, Heft 1 (2020), 2-7
- Creator
-
Boelaarts, Leo
de Jonghe, Jos F.M.
Scheltens, Philip
- DOI
-
10.1159/000506332
- URN
-
urn:nbn:de:101:1-2020100100255598292983
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Boelaarts, Leo
- de Jonghe, Jos F.M.
- Scheltens, Philip
Other Objects (12)
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer’s disease: Validation in a large memory clinic population
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer’s disease: Validation in a large memory clinic population
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies